Cargando…
Restricting HIV-1 pathways for escape using rationally designed anti–HIV-1 antibodies
Recently identified broadly neutralizing antibodies (bNAbs) that potently neutralize most HIV-1 strains are key to potential antibody-based therapeutic approaches to combat HIV/AIDS in the absence of an effective vaccine. Increasing bNAb potencies and resistance to common routes of HIV-1 escape thro...
Autores principales: | Diskin, Ron, Klein, Florian, Horwitz, Joshua A., Halper-Stromberg, Ariel, Sather, D. Noah, Marcovecchio, Paola M., Lee, Terri, West, Anthony P., Gao, Han, Seaman, Michael S., Stamatatos, Leonidas, Nussenzweig, Michel C., Bjorkman, Pamela J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3674693/ https://www.ncbi.nlm.nih.gov/pubmed/23712429 http://dx.doi.org/10.1084/jem.20130221 |
Ejemplares similares
-
Enhanced HIV-1 immunotherapy by commonly arising antibodies that target virus escape variants
por: Klein, Florian, et al.
Publicado: (2014) -
P09-06. HIV-1 escape from broadly neutralizing anti-CD4 binding site NAbs during HIV-1 infection
por: Sather, D, et al.
Publicado: (2009) -
Structure of a clade C HIV-1 gp120 bound to CD4 and CD4-induced antibody reveals anti-CD4 polyreactivity
por: Diskin, Ron, et al.
Publicado: (2010) -
Characteristics of the Earliest Cross-Neutralizing Antibody Response to HIV-1
por: Mikell, Iliyana, et al.
Publicado: (2011) -
Structural basis for germline gene usage of a potent class of antibodies targeting the CD4 binding site of HIV-1 gp120
por: West, AP, et al.
Publicado: (2012)